IGFBP3 and neoplasm: In vitro, HBx has been documented to disturb the host DNA methylation system by up-regulating DNMT expression and activities, which in turn results in hypermethylation and repression of some tumor suppressor genes (insulin-like growth factor binding protein-3 gene, E-cadherin), thus increasing tumor susceptibility [29–31].